Cross-validation of the Tunisian version of the National Eye Institute Visual Function Questionnaire 25

Author(s):  
I. Ksiaa ◽  
M. Kechida ◽  
S. Ben Tkhayat ◽  
S. El Mhamdi ◽  
N. Abroug ◽  
...  
Author(s):  
Luciano Mesquite Simmo ◽  
Carissa Fouad Ibrahim ◽  
Senice Alvarenga Rodrigues Silva ◽  
Thai Nunes Andrade ◽  
Doora Faleiros Leite ◽  
...  

Objective: To compare the vision-targeted health related quality of life (HRQOL) between neuro-ophthalmological patients and other eye diseases by the National Eye Institute 25-Item Visual Function Questionnaire. Methods: Cross sectional study with a control group and patients with the following pathologies: primary open-angle glaucoma (POAG), diabetic retinopathy (DR), age-related macular degeneration (ARMD), non-arteritic ischemic optic neuropathy (NAION), intracranial hypertension (IH), optic neuritis (ON), ptosis and cataract. Results: All comparisons of the subscales scores among the control group and the patient groups were statistically significant (p<0.05) except for “ocular pain” (p=0.160), “social functioning” (p=0.052) and “peripheral vision” (p=0.112). The control group had the best scores across all dimensions of the NEI VFQ-25. Interestingly, the ARMD and cataract groups presented the best and worst total scores of NEI VFQ-25, respectively. The lowest subscales scores were found in the cataract, in the NAION/ON, and in the POAG groups. Finally, the comparison between the NAION/ON/IH patients and the other eye diseases did not show statistical significance in any subscale. Conclusion: The NEI VFQ-25 showed the impact of various eye conditions in vision-targeted HRQOL, and no difference was measured between neuro-ophthalmological patients and other eye diseases


2016 ◽  
Vol Volume 10 ◽  
pp. 1939-1944
Author(s):  
Tadashi Nakano ◽  
Motoko Kawashima ◽  
Yoshimune Hiratsuka ◽  
Tamura Hiroshi ◽  
Koichi Ono ◽  
...  

2013 ◽  
Vol 16 (3) ◽  
pp. 569-577 ◽  
Author(s):  
Barbara Gazolla de Macedo ◽  
Leani Souza Máximo Pereira ◽  
Fábio Lopes Rocha ◽  
Aldemar N. Brandão Vilela de Castro

INTRODUÇÃO: O medo de cair é definido como baixa autoeficácia ou confiança no próprio equilíbrio para evitar quedas, causando declínio no desempenho físico e funcional, alterações no equilíbrio e na marcha dos idosos, tendo impacto negativo na qualidade de vida. Vários estudos têm identificado o déficit visual como fator contributivo para a ocorrência de quedas e do medo de cair em idosos. OBJETIVOS: Avaliar a associação entre o medo de cair e as alterações na visão funcional e na qualidade de vida relacionada à visão de idosos com catarata. MÉTODOS: Trata-se de estudo observacional com 139 idosos com catarata (71,4±6,2 anos). A qualidade de vida relacionada à visão foi avaliada pelo Visual Function Questionnaire (VFQ) e a preocupação com a possibilidade de quedas foi avaliada pela Falls Efficacy Scale International (FES-I-Brasil). RESULTADOS: Idosos que relataram algum grau de medo de cair apresentaram médias mais altas na escala FES-I-Brasil, quando comparados aos que não o relataram, indicando maior preocupação com a possibilidade de cair (p=0,000; Kruskal-Wallis). Com relação à visão funcional (VFQ) e à qualidade de vida relacionada à visão, quanto maior o medo de cair, piores eram a visão e a qualidade de vida (p=0,003; Kruskal-Wallis). CONCLUSÃO: Idosos com catarata e com relato de medo de cair apresentaram menor confiança no seu equilíbrio para evitar quedas e pior qualidade na visão funcional e na qualidade de vida relacionada à visão.


2000 ◽  
Vol 6 (6) ◽  
pp. 382-385 ◽  
Author(s):  
Laura J Balcer ◽  
Monika L Baier ◽  
Amy M Kunkle ◽  
Richard A Rudick ◽  
Bianca Weinstock-Guttman ◽  
...  

Visual impairment is one of the most common clinical manifestations of Multiple Sclerosis (MS), and is strongly related to overall health-related quality of life (HRQOL) in MS and other disorders. However, the assessment of vision-specific HRQOL in patients with MS has been limited. The purpose of this study was to examine self-reported visual dysfunction in a clinically heterogeneous MS cohort using the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). The VFQ-25 was administered by telephone interview to a subset of participants in a follow-up study to a phase III trial of interferon β-1a for relapsing-remitting MS. Mean VFQ-25 composite scores and selected sub-scale scores were significantly lower (worse) among patients in our MS cohort (n=35) compared with a published reference group of patients with no history of chronic eye disease (n=118). These differences were observed despite a relatively younger age and tighter distribution of binocular visual acuities in the MS cohort. Patients with MS in this study thus demonstrated a greater degree of self-reported visual dysfunction, as measured by the VFQ-25, compared with an eye disease-free reference group. The VFQ-25 is a potentially useful measure of vision-specific HRQOL in patients with MS.


Author(s):  
Yoshimi Suzukamo ◽  
Tetsuro Oshika ◽  
Mitsuko Yuzawa ◽  
Yoshihiro Tokuda ◽  
Atsuo Tomidokoro ◽  
...  

2005 ◽  
Vol 3 ◽  
pp. S99
Author(s):  
Yukako Ogawa ◽  
Masakazu Yamada ◽  
Asako Mori ◽  
Mokoto Kawashima ◽  
Reiko Arita ◽  
...  

2011 ◽  
Vol 21 (2) ◽  
pp. 323-334 ◽  
Author(s):  
Jonathan W. Kowalski ◽  
Anne M. Rentz ◽  
John G. Walt ◽  
Andrew Lloyd ◽  
Jeff Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document